Reassessing Phreesia (PHR) Valuation Following Positive Analyst Insights and Earnings Projections
Analyst Outlook: Phreesia (PHR) is gaining attention due to positive analyst predictions for its upcoming quarterly results, with expectations of higher earnings and revenue despite a recent decline in stock price.
Valuation Insights: The current share price of $20.29 is significantly below the estimated fair value of $33.73, indicating potential undervaluation, while a more aggressive DCF model suggests a fair value near $74.20.
Growth Drivers: The company is expanding its recurring revenue through new modules and AI integration, which are expected to enhance growth and margins, although competition and regulatory changes pose risks.
Investment Considerations: While Phreesia appears undervalued, investors are encouraged to assess the assumptions behind growth and margin projections, and consider broader market opportunities in healthcare stocks.
Trade with 70% Backtested Accuracy
Analyst Views on PHR
About PHR
About the author
Is Waystar Capable of Competing with Increasing Rivals?
Company Overview: Waysstar Holding Corp. has established a strong reputation in the healthcare and cloud computing sectors, offering powerful software-as-a-service (SaaS) solutions that integrate payer networks with electronic health records.
Market Competition: The company faces increasing competition from similar firms like Phreesia Inc. and Doximity Inc., which may impact its market share, as Waysstar's shares have declined by 40% over the past year.
Financial Performance: Despite recent challenges, analysts predict growth across multiple metrics for Waysstar, including earnings and share price, with a reported net revenue retention of 113% for the latest quarter.
Acquisitions and Growth Strategy: Waysstar is expanding through acquisitions, including its recent purchase of Iodine Software, which is expected to enhance its market presence and revenue generation capabilities.
Barron’s Stock Selections Outperform the Market in 2025: Insights on Our Successes and Missteps.
Market Volatility: A little chaos in the market can create opportunities for stock-picking, allowing investors to identify undervalued stocks.
Investment Strategy: Embracing market fluctuations can lead to better investment decisions, as it encourages a more active approach to stock selection.
Phreesia Shares Have Plummeted, But We Maintain Our Recommendation.
Stock Performance: Some stocks are performing well, while others are struggling, highlighting a mixed market environment.
Phreesia's Status: Phreesia is mentioned as a stock that does not fit neatly into the categories of hot or cold, suggesting a unique position in the market.
Phreesia Ranked Top 10 in Software Report's 2025 Software Companies List for Fourth Consecutive Year
- Industry Recognition: Phreesia has been named one of the Top 50 Software Companies by The Software Report for the fourth consecutive year, achieving its first Top 10 ranking, which highlights its excellence in product quality, organizational strength, and company culture.
- Innovative Technology: In 2025, Phreesia introduced Phreesia VoiceAI, which utilizes conversational automation to assist healthcare organizations in managing phone calls, thereby enhancing patient experience and solidifying its leadership in the healthcare software sector.
- Market Impact: In 2024, Phreesia enabled approximately 170 million patient visits, accounting for 1 in 7 visits across the U.S., demonstrating its significant contribution to patient activation and healthcare efficiency improvements.
- Strategic Vision: CEO Chaim Indig emphasized that this recognition reflects the company's commitment to simplifying interactions between patients and providers, with plans to continue advancing digital solutions to improve healthcare outcomes.
Reasons Behind Phreesia's 23% Stock Decline Today
Phreesia's Earnings Report: Phreesia reported a 13% year-over-year revenue increase to over $120 million and achieved a net profit of nearly $4.3 million, surpassing analyst expectations.
Investor Reaction: Despite the positive earnings, the stock plummeted by over 23% due to a slight miss in revenue guidance, which disappointed investors.
Revenue Streams Growth: All three of Phreesia's revenue streams—subscription services, network solutions, and payment processing—grew at low double-digit rates during the quarter.
Future Outlook: Phreesia tightened its full-year revenue guidance to $479 million to $481 million, while analysts had higher expectations of nearly $486 million, indicating potential challenges ahead.
Significant Options Activity on Tuesday: SPOT, AAP, PHR
Advance Auto Parts Options Activity: Advance Auto Parts Inc (AAP) has seen a significant options volume of 8,843 contracts today, equating to about 884,300 underlying shares, which is 68.6% of its average daily trading volume over the past month.
High Volume Call Option for AAP: The $100 strike call option expiring on January 16, 2026, has particularly high activity, with 3,565 contracts traded, representing approximately 356,500 underlying shares.
Phreesia Inc Options Activity: Phreesia Inc (PHR) has recorded an options volume of 6,704 contracts today, representing around 670,400 underlying shares, or 67.4% of its average daily trading volume over the past month.
High Volume Call Option for PHR: The $20 strike call option expiring on December 18, 2026, has seen notable trading, with 2,454 contracts exchanged, corresponding to approximately 245,400 underlying shares.
Is Waystar Capable of Competing with Increasing Rivals?
Company Overview: Waysstar Holding Corp. has established a strong reputation in the healthcare and cloud computing sectors, offering powerful software-as-a-service (SaaS) solutions that integrate payer networks with electronic health records.
Market Competition: The company faces increasing competition from similar firms like Phreesia Inc. and Doximity Inc., which may impact its market share, as Waysstar's shares have declined by 40% over the past year.
Financial Performance: Despite recent challenges, analysts predict growth across multiple metrics for Waysstar, including earnings and share price, with a reported net revenue retention of 113% for the latest quarter.
Acquisitions and Growth Strategy: Waysstar is expanding through acquisitions, including its recent purchase of Iodine Software, which is expected to enhance its market presence and revenue generation capabilities.
Barron’s Stock Selections Outperform the Market in 2025: Insights on Our Successes and Missteps.
Market Volatility: A little chaos in the market can create opportunities for stock-picking, allowing investors to identify undervalued stocks.
Investment Strategy: Embracing market fluctuations can lead to better investment decisions, as it encourages a more active approach to stock selection.
Phreesia Shares Have Plummeted, But We Maintain Our Recommendation.
Stock Performance: Some stocks are performing well, while others are struggling, highlighting a mixed market environment.
Phreesia's Status: Phreesia is mentioned as a stock that does not fit neatly into the categories of hot or cold, suggesting a unique position in the market.
Phreesia Ranked Top 10 in Software Report's 2025 Software Companies List for Fourth Consecutive Year
- Industry Recognition: Phreesia has been named one of the Top 50 Software Companies by The Software Report for the fourth consecutive year, achieving its first Top 10 ranking, which highlights its excellence in product quality, organizational strength, and company culture.
- Innovative Technology: In 2025, Phreesia introduced Phreesia VoiceAI, which utilizes conversational automation to assist healthcare organizations in managing phone calls, thereby enhancing patient experience and solidifying its leadership in the healthcare software sector.
- Market Impact: In 2024, Phreesia enabled approximately 170 million patient visits, accounting for 1 in 7 visits across the U.S., demonstrating its significant contribution to patient activation and healthcare efficiency improvements.
- Strategic Vision: CEO Chaim Indig emphasized that this recognition reflects the company's commitment to simplifying interactions between patients and providers, with plans to continue advancing digital solutions to improve healthcare outcomes.
Reasons Behind Phreesia's 23% Stock Decline Today
Phreesia's Earnings Report: Phreesia reported a 13% year-over-year revenue increase to over $120 million and achieved a net profit of nearly $4.3 million, surpassing analyst expectations.
Investor Reaction: Despite the positive earnings, the stock plummeted by over 23% due to a slight miss in revenue guidance, which disappointed investors.
Revenue Streams Growth: All three of Phreesia's revenue streams—subscription services, network solutions, and payment processing—grew at low double-digit rates during the quarter.
Future Outlook: Phreesia tightened its full-year revenue guidance to $479 million to $481 million, while analysts had higher expectations of nearly $486 million, indicating potential challenges ahead.
Significant Options Activity on Tuesday: SPOT, AAP, PHR
Advance Auto Parts Options Activity: Advance Auto Parts Inc (AAP) has seen a significant options volume of 8,843 contracts today, equating to about 884,300 underlying shares, which is 68.6% of its average daily trading volume over the past month.
High Volume Call Option for AAP: The $100 strike call option expiring on January 16, 2026, has particularly high activity, with 3,565 contracts traded, representing approximately 356,500 underlying shares.
Phreesia Inc Options Activity: Phreesia Inc (PHR) has recorded an options volume of 6,704 contracts today, representing around 670,400 underlying shares, or 67.4% of its average daily trading volume over the past month.
High Volume Call Option for PHR: The $20 strike call option expiring on December 18, 2026, has seen notable trading, with 2,454 contracts exchanged, corresponding to approximately 245,400 underlying shares.
